Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
SHSE:600276
Jiangsu Hengrui Medicine
|
44.75 | 40,42% | 78,67% | 284.545,55 | 0,45% | 1,61% |
|
SZSE:000538
Yunnan Baiyao Group Co.,Ltd
|
55.31 | 91,49% | 100,48% | 100.792,99 | 3,76% | 1,42% |
|
SHSE:600085
Beijing Tongrentang
|
46.33 | 0% | 0% | 61.304,72 | 1,08% | 6,92% |
|
SZSE:000999
China Resources Sanjiu Medical
& Pharmaceutical |
61.80 | 28,29% | 45,35% | 60.160,64 | 2,43% | 14,37% |
|
SZSE:000963
Huadong Medicine
|
33.25 | 5,75% | 30,76% | 59.084,79 | 1,74% | 4,04% |
|
SHSE:600196
Shanghai Fosun Pharmaceutical (Group)
|
23.78 | 90,1% | 181,68% | 58.251,4 | 1,14% | -2,01% |
|
SEHK:874
Guangzhou Baiyunshan Pharmaceutical
Holdings Company |
23.55 | 66,89% | 0% | 53.844,3 | 3,44% | 5,05% |
|
SHSE:600079
Humanwell Healthcare (Group)
|
20.28 | 7,17% | 26,49% | 33.688,73 | 2,27% | 33,1% |
|
SHSE:600998
Jointown Pharmaceutical Group
|
7.90 | 0% | 0% | 31.792,74 | 3,16% | 7,69% |
|
SZSE:000513
Livzon Pharmaceutical Group
|
36.98 | 0% | 0% | 28.754,16 | 4,49% | 6,03% |
|
SHSE:600062
China Resources Double-Crane Pharmaceutical
|
22.64 | 0% | 0% | 23.788,79 | 1,14% | 13,43% |
|
SEHK:6600
SciClone Pharmaceuticals (Holdings)
|
18.26 | 0% | 0% | 10.936,55 | 0% | 9,77% |
|
SHSE:600812
North China Pharmaceutical Company.Ltd
|
5.20 | 0% | 0% | 8.887,48 | 0,19% | 0% |
|
SHSE:600664
Harbin Pharmaceutical Group
|
2.80 | 0% | 0% | 7.293,2 | 0% | 0% |
|
SZSE:002693
Hainan Shuangcheng Pharmaceuticals
|
5.36 | 0% | 0% | 3.187,23 | 0% | 0% |
